| Solid lipid nanoparticles for parenteral drug delivery SA Wissing, O Kayser, RH Müller Advanced drug delivery reviews 56 (9), 1257-1272, 2004 | 1970 | 2004 |
| Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future RH Müller, C Jacobs, O Kayser Advanced drug delivery reviews 47 (1), 3-19, 2001 | 1819 | 2001 |
| Jamu: Indonesian traditional herbal medicine towards rational phytopharmacological use HJ Woerdenbag, O Kayser Journal of herbal medicine 4 (2), 51-73, 2014 | 600 | 2014 |
| The impact of nanobiotechnology on the development of new drug delivery systems O Kayser, A Lemke, N Hernandez-Trejo Current pharmaceutical biotechnology 6 (1), 3-5, 2005 | 530 | 2005 |
| Natural products as antiparasitic drugs O Kayser, AF Kiderlen, SL Croft Parasitology research 90, S55-S62, 2003 | 522 | 2003 |
| Amphotericin b A Lemke, AF Kiderlen, O Kayser Applied microbiology and biotechnology 68, 151-162, 2005 | 449 | 2005 |
| Best practice in research–overcoming common challenges in phytopharmacological research M Heinrich, G Appendino, T Efferth, R Fürst, AA Izzo, O Kayser, ... Journal of Ethnopharmacology 246, 112230, 2020 | 384 | 2020 |
| Antibacterial activity of extracts and constituents of Pelargonium sidoides and Pelargonium reniforme O Kayser, H Kolodziej Planta medica 63 (06), 508-510, 1997 | 335 | 1997 |
| Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide C Jacobs, O Kayser, RH Müller International Journal of Pharmaceutics 196 (2), 161-164, 2000 | 333 | 2000 |
| Tropane alkaloids: chemistry, pharmacology, biosynthesis and production KL Kohnen-Johannsen, O Kayser Molecules 24 (4), 796, 2019 | 313 | 2019 |
| Formulation of amphotericin B as nanosuspension for oral administration O Kayser, C Olbrich, V Yardley, AF Kiderlen, SL Croft International journal of pharmaceutics 254 (1), 73-75, 2003 | 295 | 2003 |
| Lipid-drug-conjugate (LDC) nanoparticles as novel carrier system for the hydrophilic antitrypanosomal drug diminazenediaceturate C Olbrich, A Gessner, O Kayser, RH Müller Journal of drug targeting 10 (5), 387-396, 2002 | 250 | 2002 |
| Rhodomyrtone: A new candidate as natural antibacterial drug from Rhodomyrtus tomentosa S Limsuwan, EN Trip, TRHM Kouwen, S Piersma, A Hiranrat, ... Phytomedicine 16 (6-7), 645-651, 2009 | 238 | 2009 |
| Nanosuspensions of poorly soluble drugs—reproducibility of small scale production MJ Grau, O Kayser, RH Müller International journal of pharmaceutics 196 (2), 155-159, 2000 | 233 | 2000 |
| Analysis of cannabinoids in laser-microdissected trichomes of medicinal Cannabis sativa using LCMS and cryogenic NMR N Happyana, S Agnolet, R Muntendam, A Van Dam, B Schneider, ... Phytochemistry 87, 51-59, 2013 | 222 | 2013 |
| Endophytic fungi harbored in Cannabis sativa L.: diversity and potential as biocontrol agents against host plant-specific phytopathogens P Kusari, S Kusari, M Spiteller, O Kayser Fungal diversity 60, 137-151, 2013 | 215 | 2013 |
| Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN)—effect of surfactants, storage time and crystallinity C Olbrich, O Kayser, RH Müller International journal of pharmaceutics 237 (1-2), 119-128, 2002 | 215 | 2002 |
| Endophytes: exploiting biodiversity for the improvement of natural product-based drug discovery A Staniek, HJ Woerdenbag, O Kayser Journal of plant interactions 3 (2), 75-93, 2008 | 195 | 2008 |
| Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosis N Schöler, K Krause, O Kayser, RH Müller, K Borner, H Hahn, ... Antimicrobial agents and chemotherapy 45 (6), 1771-1779, 2001 | 194 | 2001 |
| Anti-cancer and antibacterial trioxacarcins with high anti-malaria activity from a marine Streptomycete and their absolute stereochemistry RP Maskey, E Helmke, O Kayser, HH Fiebig, A Maier, A Busche, ... The Journal of antibiotics 57 (12), 771-779, 2004 | 189 | 2004 |